LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC) (the “Company”) is aware of a news article published today by Reorg®, citing anonymous sources.
The article contains unsubstantiated rumors, including that the company is considering bankruptcy or insolvency proceedings of any kind – this is not the case.
We understand that Reorg® has subsequently issued an update to its original press article to clarify that the Company has not been involved in discussions with its creditors regarding bankruptcy proceedings.
It is the Company’s policy not to provide further comment on speculation.
About Bausch Health
Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC) is a diversified global pharmaceutical company that enriches lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products mainly in the fields of gastroenterology, hepatology, neurology, dermatology, medical-aesthetic devices, international pharmaceuticals and eye health, through to our majority stake in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company trusted and valued by patients, healthcare professionals, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking statements
This press release may contain forward-looking statements about the future performance of Bausch Health, which generally can be identified by the use of the words “will”, “anticipates”, “hopes”, “expects”, “has the “intend”, “anticipate”, “should”, “could”, “would”, “could”, “believe”, “subject to” and variations or similar expressions. These statements are based on expectations and beliefs management and are subject to certain risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate to Bausch Health’s overall business more broadly, including those described in more detail. in Bausch Health’s most recent annual and quarterly reports and detailed from time to time in Bausch Health’s other filings with the United States Securities and Exchange. Commission and the Canadian Securities Administrators, factors incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual results, except as required by law.